baff-april

Kidney Week in Denver: Day 3

Kidney Week in Denver: Day 3

Day 3 : yet another IgA trial, and we are back with some flozin news: in ADPKD, their effect on hemoglobin, and on BP (with finerenone)

ORIGIN 3 interim-story: atacicept in IgAN

Check out ORIGIN 3 recap: a 36-week, interim analysis of phase 3 trial of atacicept in IgAN! Thread by NephJC intern Marc Soco.

ORIGIN-3: El Resumen Visual

ORIGIN-3 ha llegado a NephJC con atacicept en NIgA.
Un paso sólido hacia una terapia dirigida anti BAFF/APRIL, que aborda la fisiopatología desde su origen. ¡Las señales tempranas son prometedoras!

Revisa el resumen visual realizado por Clemens Weber